January 2014

Testosterone therapy may double heart attack risk ()
Findings challenge donor heart allocation process ()
CMR may help risk stratify CAD patients ()
ACC.14: ACC unveils list of late-breakers ()
Expanded PCI improving treatment times in U.K. ()
TAVR insights ()
Inhospital mortality leaps after TAVR commercialization ()
DuPage Medical Group acquires cardiology practice ()
Mortality lower with VADs, but readmissions still high ()
Aspirin may be overprescribed in patients with AF ()
1 in 7 surgeries deemed cardiovascular procedures ()
Hospital pays $16.5M to settle cardiologists’ fraud case ()
Combo AF therapy may not lower risk of coronary events, thromboembolism ()
Judge allows Riata lawsuits to move forward ()
Survival good 15 years after pediatric heart transplants ()
Temple surgeon working to bring new stent for aortic aneurysms to patients in the U.S. ()
Edwards receives European approval for advanced Sapien 3 valve ()
TAVR centers see jump in surgical AVR volumes ()
End-of-life directives rarely include device deactivation ()
Low-risk chest pain may account for most PCI readmissions ()
Multiple CPR attempts costlier in terms of dollars & survival ()
Repeat cryoablation may offer long-term freedom for some AF patients ()
Management plan shouldn’t differ for cancer survivors ()
Serelaxin hits roadblock in Europe ()
Home BP measurements may predict cardiovascular risk better ()
Twice yearly doc visits for hypertension exemplify excessive care ()
Bioresorbable scaffolds show early promise in peripheral arteries ()
Evidence on efficacy of ICDs at preventing SCD mixed ()
Amgen announces positive top-line results from phase 3 GAUSS-2 Trial of Evolocumab (AMG 145) in statin intolerant patients with high cholesterol ()
Safety first ()
MI outcomes may be worse when treated during off-hours ()
Covidien drops renal denervation program ()
Adverse event rates for hospitalized MI, CHF declining ()
Medtronic Surescan(r) pacing systems first to be approved for full body MRI scans without positioning restrictions ()
Mehta elected as Ohio’s first female governor for American College of Cardiology ()
Arizona Heart Foundation expands student education with nine Toshiba ultrasound units ()
Today’s CIEDs: A hodgepodge of PMA supplements? ()
Anatomic burden better predictor than ischemic burden ()
Mediterranean diet may hold off PAD in high-risk patients ()
Edwards wins latest TAVR patent tussle ()
Coronary angiography pioneer Sven Paulin dies ()
pVAD safer, more cost-effective than surgical alternatives ()
Q&A: Co-PI Jeffrey Popma on CoreValve’s FDA approval ()
Antibiotics linked to warfarin over-anticoagulation ()
Hold the needle: Multistage screening as good as lab testing ()
Commonly used carotid stent systems found to be safe ()
FDA approves CoreValve for inoperable patients ()
Report targets cognitive outcomes after cardiovascular procedures ()
FDA panel united against approval of Xarelto ()
Package flaws prompt Merck to recall Liptruzet ()
Rates for outpatient angina visits take steep drop ()
Doc dissent offers opportunity for patients ()
Guidelines: Good, bad & unreimbursed ()
Vorapaxar gets 10-1 thumbs up from FDA panel ()
Eyeball test may not see risk accurately ()
Stem cells may not improve post-STEMI LV function ()
Daiichi Sankyo submits SAVAYSATM (edoxaban) tablets New Drug Application to the U.S. FDA for once-daily use for stroke risk reduction in atrial fibrillation and for the treatment and prevention of recurrence of venous thromboembolism ()
Cholesterol guidelines: Try mixing old with new ()
Evidence doesn't support higher SBP goal, panel members argue ()
Creatine MRI may spot heart damage earlier ()
Dense coronary artery plaque may lower heart disease risk ()
Appealing RAC decision? Wait in line ()
Options when proper care & reimbursement don’t align ()
ESC to cardiologists: Bone up on radiation’s risks ()
Hospital quality tied to racial disparity in post-CABG deaths ()
DOJ subpoenas Aegerion over Juxtapid ()
Vorapaxar, rivaroxaban up for review ()
Guidelines help docs manage patients on novel anticoagulants ()
Clinical services, research and education greatly enhanced by new collaborations for CHI, St. Luke’s, Baylor College of Medicine and Texas Heart Institute ()
SYMPLICITY HTN-3 falls short on effectiveness ()
Just say no ()
ICDs do not improve outcomes in some post-PCI STEMI patients ()
Patterson joins N.Y. hospital as senior VP, COO ()
Clopidogrel plus aspirin fails to reduce risk after lacunar stroke ()
Patent Foramen Ovale: To Close or Not to Close? ()
Can-do Cath Labs: Improving PCI Outcomes & Efficiency ()
ACC Corner | Cardiologists Succeed in Qualifying for Meaningful Use Incentive Payments ()
Readmission Penalties: RNs to the Rescue ()
Q&A: ACC/AHA’s Provocative Prevention Guidelines ()
Remorse Code: Mistakes that Prompt an Audit ()
Choosing TAVR ()
PTSD & Heart Disease: A Vicious Cycle ()
People & Progress ()
In-hospital STEMI may carry worse outcomes ()
New Kcentra label includes urgent reversal of warfarin in an emergency surgery setting ()
California's first robotically assisted coronary stenting procedure performed at UC San Diego Sulpizio Cardiovascular Center ()
Icahn School of Medicine at Mount Sinai named to new NIH Stroke Research Network ()
American College of Physicians launches 'Online High Value Care Cases' ()
Fixing docs’ finances instead of patients ()
Strategies to up thrombolysis rates provide cost savings ()
Shingles raises later risk for vascular events ()
Blood conservation strategy lowers transfusion risk during AVR ()
Cardiology, radiology specialists still command top pay ()
Boston Scientific names Craig Thompson, M.D. as new Chief Medical Officer, Interventional Cardiology ()
Patch challenges Holter monitor for detecting arrhythmias ()
Mechanical CPR no better than manual ()
Telestroke services save money, improve outcomes ()
Dabigatran protocol open for comment until Jan. 13 ()
Targeting comorbidities may reduce avoidable readmissions ()
Abbott pays $5M to settle kickback charges ()
Preparing for change ()
Timing of antibiotics may reduce cardiac surgery-related infections ()
2014 health to-do list: See cardiologist ()